Celebrate Parkinson’s Awareness Month With Your Institute
April is Parkinson’s Awareness Month, and the Parkinson’s Institute and Clinical Center is celebrating in a big way by announcing that last year's MORE TALK! MORE WALK! 2-mile fundraiser walk is merging with Parkinson's Battle of the Bay to form a family friendly sports tournament on Saturday, April 8th at Baylands Park in Sunnyvale! Participants can sign up for a 2-mile Walk, Sports Tournament (flag football, volleyball, kickball), or both.
Sign-up online today at PDBattleoftheBay.com or call event manager, Nick Mourlam, at 408.542.5637
$1.9 million grant from CIRM for research
The California Institute for Regenerative Medicine has made a $1.9 million grant to the Institute for Dr. Birgitt Schuele, MD, Associate Professor, Program Director of Gene Discovery and Stem Cell Modeling to study the effects of downregulation of a key protein implicated in Parkinson’s disease as a potential novel gene therapy approach. “Alpha-synuclein has been a leading target since its discovery in 1997 as a Parkinson’s gene and the observation that alpha-synuclein is a main neuropathological hallmark of Parkinson’s, called Lewy bodies can now be studied with this grant,” says Dr. Schuele.
UCB Collaborates on Parkinson’s Insight Project
We are excited about our collaboration with UCB, developers of Neupro® (rotigiotine transdermal system), a 24 hour time release patch which provides people with Parkinson’s continuous and stable delivery of their medication. UCB is working with us on our Parkinson’s Insight project to advance the understanding of medications used to treat Parkinson’s outside of a controlled clinical setting. Ideally, this study will help us deliver optimal healthcare for people living with Parkinson’s.
2017 Parkinson's Unity Walk
If you're interested in traveling to New York, join us at the 2017 Parkinson’s Unity Walk on Saturday, April 22nd. 100% of donations support research funded by six major Parkinson’s foundations. Learn more at www.UnityWalk.org
Parkinson’s Institute and Clinical Center Excited to Partner with CENTOGENE
The Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of a large cohort of Parkinson’s patients in the US. Now, individual patients will be screened using a large customized panel carefully selected to identify pathophysiological relevant genetic variants for the development and treatment of Parkinson’s disease. For more information click here